Spironolactone Tablet
Product Images NDC 71335-2217

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

This text appears to be a result or analysis of a study involving a medication called "Spironolactone" and a placebo. It mentions a log-rank p-value of less than 0.001, indicating a significant difference between the two groups. The text also includes a timeline of 4, 6, 12, 18, 24, 30, 36, 42, and 48 months, suggesting that the study may have lasted for this duration.*

FDA Label Image

Figure 2 (Spironolactone 03)

FDA Label Image

Label (Lbl713352217)

This is a description of a medication called Spironolactone. Each tablet contains 25 mg of Spironolactone. The medication is stored at a temperature range of 20° to 25°C (68° to 77°F). It is important to keep this medication out of reach of children and store it in a tight, light-resistant container. The medication is manufactured by Bryant Ranch Prepack, Inc. and relabeled by Frontida BioPharm, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.